针对多种脑肿瘤设计自适应分割流程,提升精准度与临床可用性。
Adaptable Segmentation Pipeline for Diverse Brain Tumors with Radiomic-Guided Subtyping and Lesion-Wise Model Ensemble
- 根据影像特征自动识别肿瘤亚型,动态选择最优模型组合
- 在多类脑肿瘤数据集上达到顶尖水平的分割准确率
- 适合临床量化分析,助力诊断与预后判断
多参数磁共振成像(MRI)中脑肿瘤的鲁棒且泛化性强的分割仍具挑战,因肿瘤类型差异大。BraTS 2025 Lighthouse Challenge 在包含成人与儿童肿瘤的高质量数据集上评估分割方法:多中心国际儿童脑肿瘤分割(PED)、术前脑膜瘤分割(MEN)、脑膜瘤放疗分割(MEN-RT)以及治疗前后脑转移瘤分割(MET)。我们提出一种灵活、模块化、可自适应的分割流程,通过选择并组合先进模型,并在训练前后实施肿瘤与病灶级特异性处理,提升分割性能。从MRI中提取的放射组学特征用于识别肿瘤亚型,确保训练样本分布更均衡。基于病灶级性能指标确定各模型在集成中的权重,并优化后处理步骤以进一步精炼预测结果,使整个工作流能针对每个病例定制每一步。在BraTS测试集上,本方法表现媲美顶级算法,在多个挑战中均达领先水平。结果表明,病灶感知的处理与模型选择策略可实现稳健分割,且不依赖特定网络架构。该方法具备临床量化肿瘤测量潜力,支持诊断与预后。
原文摘要 · Abstract (English)
Robust and generalizable segmentation of brain tumors on multi-parametric magnetic resonance imaging (MRI) remains difficult because tumor types differ widely. The BraTS 2025 Lighthouse Challenge benchmarks segmentation methods on diverse high-quality datasets of adult and pediatric tumors: multi-consortium international pediatric brain tumor segmentation (PED), preoperative meningioma tumor segmentation (MEN), meningioma radiotherapy segmentation (MEN-RT), and segmentation of pre- and post-treatment brain metastases (MET). We present a flexible, modular, and adaptable pipeline that improves segmentation performance by selecting and combining state-of-the-art models and applying tumor- and lesion-specific processing before and after training. Radiomic features extracted from MRI help detect tumor subtype, ensuring a more balanced training. Custom lesion-level performance metrics determine the influence of each model in the ensemble and optimize post-processing that further refines the predictions, enabling the workflow to tailor every step to each case. On the BraTS testing sets, our pipeline achieved performance comparable to top-ranked algorithms across multiple challenges. These findings confirm that custom lesion-aware processing and model selection yield robust segmentations yet without locking the method to a specific network architecture. Our method has the potential for quantitative tumor measurement in clinical practice, supporting diagnosis and prognosis.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。